5 to 6 March 2023, Hilton Riyadh, KSA
HealthTech Summit & Expo, With 70+ exhibitors from 3000+ healthcare managers/executives, will showcase the latest healthcare innovations and technologies bringing together an equal opportunity event where the most promising entrepreneurs from around the world will pitch how their solutions will address current gaps and redefine healthcare to an audience of Investors over 2 nerve-wracking days!
Several topics related to the present and future of health addressed by renowned speakers in each respective field.
Startups: The Summit & Expo 2022 will have a number of Startups presenting their ideas, products or services to investors and participants. There will also be a dedicated Startup Lounge in order to potentiate networking with possible investors.
Networking: One of the main attractions of the digital health innovation summit 2022! A place for individuals, researchers, scholars, investors, startups and companies/organizations of all sizes to create synergies with one another and leverage business opportunities.
Companies/Organizations will be able to have a stand to show and present their healthcare-related solutions to interested participants that are attending, including hospitals and other healthcare providers.
Chairman of Scientific Committee
Chairman of Scientific Committee
Professor of Pharmaceutical Biotechnology
College of Pharmacy
King Saud University
Professor Ibrahim A. Alsarra received his Bachelor of Pharmacy (B.S.), in 1996 from College of Pharmacy, King Saud University, Kingdom of Saudi Arabia and his Doctor of Philosophy (Ph.D.) in Pharmaceutical Biotechnology and Drug Formulation Development, Division of Pharmaceutical Sciences, School of Pharmacy, University of Missouri-Kansas City, Missouri, USA.
He joined King Saud University in 2002 and was the Assistant Secretary for Research and Scientific Affairs, Arab Pharmacists Union as well as the Deputy Director for Research and Technical Affairs, Centre of Excellence in Biotechnology Research; the only biotechnology center in Saudi Arabia, King Saud University till 2021. He was the President of Saudi Pharmaceutical Society for two terms and the former Editor-in-Chief of Saudi Pharmaceutical Journal for six years, a peer-reviewed and ISI-Indexed Journal with an impact factor of 4.33.
Professor Alsarra research interests include; Pharmaceutical Biotechnology; Biosimilars and Biological medications, Drug Delivery, and Controlled Drug Release.
Professor Alsarra has more than 13 registered patent: (five)-US Patents, (Four)-European Patents, and (Four)- Saudi Patents. He has published and eadited several
book and bookchapters and several peer-reviewed paper in highly reputed journals (more than 186 peer-reviewed papers).
* Best Editor-in-Chief (2014), of the scientific journals hosted by King and Saud University and published by Elsevier, King Saud University, Riyadh, Saudi
Arabia.
* Recipient of King Saud University’s Award for Distinguished Scientific Research: Invention Section (faculty members across the University (2014), King Saud University, Riyadh, Saudi Arabia.
* Scientist of the Year (2014), organized by Dubai International Pharmaceuticals
and Technologies Conference and Exhibition (DUPHAT 2014), Dubai Health Authority, Dubai, United Arab Emirates.
* Recipient of King Saud University’s Award for Distinguished Research and High-
quality International Publications by faculty members across the University (2009), King Saud University, Riyadh, Saudi Arabia.
* Outstanding Scientists, International Biographical Centre, Cambridge, England (2000)
*Leading Scientists of the World (2008), Research and Editorial Departments, International Biographical Centre, Cambridge, England.
* International Scientist of the Year (2007), International Biographical Center, Cambridge, England.
* Recipient of his Royal Highness Prince Bandar Bin Sultan Award, Saudi Ambassador to the USA, for outstanding academic achievement during Doctoral studies, 2003.
* Rho Chi Society, the Pharmacy Honor Society, 2000 University of Missouri-Kansas City, Missouri 64110-2265, USA (Academic Honor).
Chief Operating Officer, SEHA
Chief Operating Officer and Acting Chief of Quality and Excellence
Seha Virtual Hospital - MOH
Assistant Professor, KFUPM
Dr. Imane Boudellioua is an Assistant Professor in the Information and Computer Science Department at King Fahd University of Petroleum and Minerals, and one of the founding female faculty members at KFUPM. She holds a PhD degree in Computer Science from King Abdullah University of Science and Technology, where she was awarded KAUST Discovery Scholarship, KAUST MSc/PhD Fellowship, and KAUST Provost Award. She is the recipient of 2020 KACST-AlMarai Prize for Scientific Creativity for her PhD thesis on machine learning methods for the prioritization of candidate causative genomic variants of Mendelian and oligogenic diseases. She is also one of the winners of KAUST TAQADAM Accelerator Program for her startup, GenomeFit, providing AI-empowered genetic diagnostics services. Her research interests are in computational genomics, and the application of machine learning and data mining in the biomedical field.
Consultant, KFSHRC
Neurology Consultant
Neurology Consultant, Epileptologist, Intraoperative Neurophysiologist
Biography:
Dr. Anas Albarrak, MD, assistant professor, Prince Sattam bin Abdulaziz University, EEG director, King Khalid University Hospital, King Saud University Medical City (KSUMC), and the founder and CEO of Neurology Solutions Company.
Dr. Albarrak graduated from the college of medicine, King Saud University. He is certified by the Saudi and European Board of Neurology. He did Epilepsy and EEG fellowship at the University of London Ontario, Canada. Also, he did Intraoperative neurophysiology monitoring fellowship at the University of Pittsburgh, Pittsburgh, Pennsylvania, US.
He is very passionate about filling the gap in neurological care in Saudi Arabia and GCC countries by making neurology services available to everyone with the best quality. He has a special interest in artificial intelligence (AI) in health care in general and in neurology in particular.
Executive Director of the Innovation Center, PSU
Executive Director of the Innovation Center
Director, Riphah Institute of Healthcare Improvement
Adjunct Professor Digital Health, HSA
CEO, Digital Care Director,
Riphah Institute of Healthcare Improvement & Safety
Ex. Director Digital Health, KSA Riyadh
Zakiuddin Ahmed is a visionary strategist, healthcare entrepreneur & a physician advocate who specializes in developing socially beneficial, sustainable & innovative solutions in Healthcare through information technology with a Patient Centric Focus. His areas of expertise are Digital Health, Patient Safety, Ethics & Research. As an invited speaker he has presented at many conferences around the world and serves on the boards of various international conferences and organizations. He is the President, Healthcare Paradigm; Project Director, Riphah Institute of Healthcare Improvement & Safety, Program Director ? RAH@H at King Saud University Riyadh; Director Digital Health at PharmEvo; CEO of Digital Care; & Project Director of RAHAT. He also holds leadership positions as President, Healthcare Quality & Safety Association of Pakistan; Founding trustee of eHealth Association of Pakistan, Secretary Health Research Advisory Board. Dr. Zaki has a Bachelor's degree in Medicine and a Master's degree in Health Management.
CEO, Cura Healthcare
CEO, Founder of Cura Healthcare, Digital Health, Speaker, Entrepreneur, KFUPM-er, ex-Microsoft
HealthTech Innovation Summit & Expo will be an industry-leading summit for healthcare professionals and C-level healthcare executives in the middle east that will take a look at using next-gen technologies to push care beyond the four walls of the hospital, connect multi-site systems to work as one, connect people to their own care, and enable integrated care to be delivered at a system level.
will feature multiple speakers renowned in different areas presenting solutions and ideas to help move health and healthcare forward. Join around 3,000 senior healthcare managers and clinicians striving to transform care and improve quality against the backdrop of Covid-19 and the challenges ahead.